Tel:
Fax:
Email:
Creative Biolabs

Pharmacological induced Anxiety Mouse Model Development Service

Are you currently facing challenges in translating preclinical anxiolytic hits to clinical success, often due to confounding sedative effects or models lacking predictive validity? Our Pharmacological-Induced Anxiety Mouse Models Development Services help you accelerate drug discovery and obtain clear, non-confounded efficacy data. This is achieved through rapid, high-throughput screening platforms and our commitment to advanced, translational physiological biomarkers, ensuring your therapeutic candidates are validated against the highest industry standards.

Workflow Advantages Available Models Offerings Related Services FAQs

How Our Pharmacological-Induced Anxiety Mouse Models Development Services Can Assist Your Project

Our service provides a clear, highly systematic pathway for the rapid validation of your novel anxiolytic compounds, grounded in real-world translational science.

Discover How We Can Help - Request a Consultation

Workflow: Precision Screening from Concept to Report

We provide a comprehensive and detailed explanation for each point in the workflow, suitable for visualization as a flowchart, making it very clear to potential clients what is involved.

Workflow of our Pharmacological-Induced Anxiety Mouse Models Development Services. (Creative Biolabs Original)

Required Starting Materials
  1. Compound structure and proposed mechanism of action (e.g., 5–HT1A agonist or GABAA modulator).
  2. Target dose range and preferred route of administration.
  3. Any known off-target toxicological data.
Final Deliverables
  1. Raw, time-stamped behavioral data files.
  2. Comprehensive Efficacy Report with statistical summaries and high-resolution graphs.
  3. Detailed Pharmacokinetic/Pharmacodynamic (PK/PD) Correlation Analysis.

Why Choose Us?

At Creative Biolabs, our commitment to Quality-by-Design (QbD) and translational rigor sets our pharmacological-induced anxiety mouse models development services apart. We offer a level of specificity and control unparalleled in preclinical screening, ensuring your data is clean, robust, and clinically relevant.

Key Advantages and Unique Features

  • Targeted Pathway Specificity: We move beyond generalized anxiety models by using agents like m-Chlorophenylpiperazine (mCPP) to specifically challenge the 5–HT2C pathway, allowing direct testing of serotonergic-targeted drugs.
  • Zero-Tolerance for Confounding Effects: Our standard protocol integrates Rotarod and Tail Suspension Test (TST) controls, guaranteeing that any observed anxiolytic effect is not a false positive caused by motor sedation or anti-depressant activity.
  • Translational Biomarker Integration: We routinely use Stress-Induced Hyperthermia (SIH) as a conserved physiological readout, providing objective evidence of HPA axis moderation—a key step towards human translation.
  • QbD-Driven Reproducibility: Every protocol adheres to Quality-by-Design principles, ensuring low inter-subject variability, high data integrity, and superior reproducibility compared to models lacking formal quality controls.

Experience the Advantage - Get a Quote Today

Pharmacological-Induced Anxiety Mouse Models

This section details the core scientific methodology behind the service, highlighting its precision in modeling acute anxiety states.

  • The Power of State Anxiety Induction

PAMM utilizes rapid-acting anxiogenic compounds or procedures to induce a temporary, yet pronounced, state of heightened anxiety. This approach is superior for early drug screening as it provides fast, reliable, and targeted results. For example, our use of mCPP—a 5–HT2C partial agonist—is highly effective for rapidly inducing a transient, severe anxiety phenotype that directly links to the central serotonergic system.

  • Gold-Standard Behavioral Phenotyping

Precise behavioral assessment is the cornerstone of PAMM validity. Our platform employs a tri-panel approach, utilizing automated video tracking systems for objective, high-resolution data capture based on the ethological principle of approach-avoidance conflict:

Behavioral Assay Primary Readout & Principle Validation Focus
Elevated Plus Maze (EPM) Time spent and entries into open arms (approach-avoidance conflict) Measures natural aversion to open, elevated spaces.
Light/Dark Box (LDB) Time spent in the light compartment and transitions between compartments Measures innate aversion to brightly lit, exposed environments.
Open Field Test (OFT) Total distance traveled and time spent in the center Crucially serves as the control for locomotor activity.

What We Can Offer

We provide end-to-end support for your anxiolytic program, from discovery screening to deep translational validation.

High-Throughput Screening Packages:

Leverage our validated PAMM protocols (mCPP, Pentylenetetrazol (PTZ), etc.) combined with core behavioral assessments (EPM, LDB, OFT) for fast, reliable compound activity determination.

Related Services

To further support your psychotropic drug development goals, CBL offers several complementary services that integrate seamlessly with our PAMM platform.

FAQs

Q Why should I choose PAMM over chronic stress models like CUMS for my screening?

A Pharmacological-Induced Anxiety Mouse Models are designed for speed and specificity. They induce a robust, acute anxiety state rapidly, making them ideal for high-throughput screening of large compound libraries. While chronic models inform on etiology, PAMM is superior for rapid Go/No-Go decisions based on predictive drug response.

Q How do you guarantee the anxiolytic effects you measure are not merely due to sedation?

A We rigorously address this by running simultaneous controls. Every anxiolytic screening is paired with an independent locomotor activity (LA) assessment using the OFT and the Rotarod Test. This protocol ensures your compound is actively reducing anxiety behavior without altering baseline motor coordination, eliminating false positives.

For more information and to discuss how our services can meet your specific project requirements, please contact our team of experts.

Contact Our Team for More Information and to Discuss Your Project.

For Research Use Only. Not For Clinical Use.
In Vivo Services
Hot Products
Fill out this form for a quote Inquiry Form Send Inquiry
USA

Tel:

Fax:

Email:

UK

Tel:

Email:

Germany

Tel:

Email:

Inquiry Basket
compare

Send inquiry